Towards Healthcare
Kidney Organ-on-a-Chip Market to Rise at 21.27% CAGR till 2034

Kidney Organ-on-a-Chip Market Shaping Future Disease Models

According to forecasts, the global kidney organ-on-a-chip market will grow from USD 192 million in 2024 to USD 1314.52 million by 2034, with an expected CAGR of 21.27%. A rise in CKD cases and advances in materials are fueling the global market. North America led the market due to rising focus on drug discovery and toxicity testing.

  • Last Updated: 16 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

FAQ's

The kidney organ-on-a-chip market is worth USD 232.84 million in 2025, and by 2034, it is forecasted to hit USD 1314.52 million, registering a CAGR of 21.27% over the decade.

North America is currently leading the kidney organ-on-a-chip market share by 40% due to the growing focus on drug discovery & toxicity testing.

Some key players include Emulate Inc., TissUse GmbH, Mimetas BV, CN Bio Innovations, and Nortis Inc. 

Bioprinted chips are miniature laboratories created to replicate the biological functions and mechanics of human organs and organ systems.

US FDA, NIH, NSF, MDPI, PIB, NCATS, NASA, CMS